13 Aug 2024
// ECONOMICTIMES
02 Aug 2024
// THEHINDUBUSINESSLINE
02 Aug 2024
// ECONOMICTIMES
Latest Content by PharmaCompass
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Booth #1B18
08-10 October, 2024
CPhI India 2024CPhI India 2024
Industry Trade Show
Booth #1.B20
26-28 November, 2024
Industry Trade Show
Not Confirmed
28-30 September, 2024
CONTACT DETAILS
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Booth #1B18
08-10 October, 2024
CPhI India 2024CPhI India 2024
Industry Trade Show
Booth #1.B20
26-28 November, 2024
Industry Trade Show
Not Confirmed
28-30 September, 2024
CORPORATE CONTENT #SupplierSpotlight
13 Aug 2024
// ECONOMICTIMES
https://health.economictimes.indiatimes.com/news/pharma/financial-performance/supriya-lifescience-reports-21-7-per-cent-y-o-y-revenue-increase-in-q1-fy24/112488153?utm_source=whatsapp_web&utm_medium=social&utm_campaign=socialsharebuttons
02 Aug 2024
// THEHINDUBUSINESSLINE
https://www.thehindubusinessline.com/companies/supriya-lifescience-promoter-wagh-familys-next-gen-to-helm-company/article68478221.ece
02 Aug 2024
// ECONOMICTIMES
https://health.economictimes.indiatimes.com/news/industry/supriya-lifescience-ltd-appoints-dr-saloni-wagh-as-md-shivani-wagh-as-joint-md-dr-satish-wagh-as-executive-chairman/112226629
08 Jul 2024
// EXPRESS PHARMA
https://www.expresspharma.in/pharma-industry-experts-eye-budget-boost-for-innovation-and-global-ambitions/
04 Jul 2024
// Sushmita Panda FINANCIAL EXPRESS
https://www.financialexpress.com/budget/budget-2024-pharma-sector-demands-substantial-rampd-incentives-tax-relief-and-strong-ip-framework-3543082/
25 Jun 2024
// Sushmita Panda FINANCIAL EXPRESS
https://www.financialexpress.com/business/healthcare-our-primary-goal-is-to-double-our-revenue-enter-higher-margin-niche-segments-and-increase-footprint-dr-saloni-wagh-director-supriya-lifescience-ltd-3533944/
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-02-07
Pay. Date : 2012-11-29
DMF Number : 23511
Submission : 2010-01-22
Status : Active
Type : II
Certificate Number : R1-CEP 2015-097 - Rev 00
Issue Date : 2023-01-19
Type : Chemical
Substance Number : 977
Status : Valid
Date of Issue : 2022-06-29
Valid Till : 2025-07-02
Written Confirmation Number : WC-0218
Address of the Firm :
NDC Package Code : 61281-3000
Start Marketing Date : 2013-10-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg. Filing : ASMF, CN, SA |
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-01-07
Pay. Date : 2021-06-16
DMF Number : 35174
Submission : 2020-09-03
Status : Active
Type : II
Certificate Number : R0-CEP 2019-120 - Rev 00
Issue Date : 2022-09-27
Type : Chemical
Substance Number : 23
Status : Valid
Date of Issue : 2022-06-29
Valid Till : 2025-07-02
Written Confirmation Number : WC-0218
Address of the Firm :
NDC Package Code : 61281-6000
Start Marketing Date : 2013-11-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg. Filing : ASMF |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36426
Submission : 2021-11-08
Status : Active
Type : II
Certificate Number : R0-CEP 2018-198 - Rev 00
Issue Date : 2021-03-01
Type : Chemical
Substance Number : 1742
Status : Valid
Date of Issue : 2022-06-29
Valid Till : 2025-07-02
Written Confirmation Number : WC-0218
Address of the Firm :
NDC Package Code : 61281-8300
Start Marketing Date : 2015-06-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg. Filing : ASMF |